Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study

Class:Id	LiteratureReference:9709151
_displayName	Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study
_timestamp	2020-12-10 13:54:44
author	[Person:9709131] Koda, Yuichi [Person:9709121] Kuribayashi, Kozo [Person:3636915] Doi, Hiroshi [Person:9709103] Kitajima, Kazuhiro [Person:9709097] Nakajima, Yasuhiro [Person:9709158] Ishigaki, Hirotoshi [Person:9709118] Nakamura, Akifumi [Person:9709111] Minami, Toshiyuki [Person:9709110] Takahashi, Ryo [Person:9709107] Yokoi, Takashi [Person:9709138] Kijima, Takashi
created	[InstanceEdit:9709130] Jassal, Bijay, 2020-12-10
journal	Oncology
pages	1-8
pubMedIdentifier	33053560
title	Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study
year	2020
(literatureReference)	[Reaction:9709109] DHFR dimer binds DHFR inhibitors [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study (9709151)